Clariant Innovation Center Cornerstone Laid at Industriepark Höchst for 500 New Research Jobs

Clariant Innovation Center Cornerstone Laid at Industriepark Höchst (Photos: Clariant)

  • Finance Minister Thomas Schäfer: Investment brings major benefits
  • Christian Kohlpaintner: 100 million euros to provide optimal conditions for sustainable, successful research

MEVOPUR® offers antimicrobial options for medical devices

  • New formulations extend the MEVOPUR® range with MedX antimicrobial additives
  • Avoidance of secondary antimicrobial coating operation supports manufacturing productivity

Clariant awarded the EU Ecolabel for its Advanced Denim Illustration Collection

Clariant’s Advanced Denim Pad/Sizing-Ox process saves 92% water, 30% energy and reduces cotton waste by 87% in denim production but does not limit design effects. (Photo: Clariant)

  • Award recognizes Clariant's ground-breaking innovation in sustainable denim production for textile industry
  • Added-value Advanced Denim process supports industry's global fashion trends and efficiency goals

New, vegetal-based biopolymers from Clariant

Touch of Nature. (Photo: Clariant)Muttenz, February 22, 2012 - At the upcoming in-cosmetics show in Barcelona, Clariant will present three new lines of biopolymers for skin and hair care under the theme “Touch of Nature”. The company also announces that it has achieved Good Manufacturing Practice (GMP) certification, according to ISO 22716, for its global cosmetics manufacturing.

Clariant shares expertise on chemical transport safety in India

Mr. Peter Palm, VC&MD - Clariant Chemicals (India) Limited (Photo: Clariant)Mumbai, February 15, 2012 – Clariant is sharing its global expertise regarding the safe transportation of chemicals in an initiative to achieve consensus on this important challenge facing the Indian chemical sector.

New Clariant MEVOPUR® additives boost pharmaceutical packaging process and performance

  • On-going expansion of dedicated portfolio for medical and pharmaceutical sector
  • Innovative solutions to differentiation and cost pressure issues in pharma packaging
  • Pre-testing of ingredients using extraction data supports customer development

Muttenz, February 15, 2012 - Clariant introduces Pharmapack 2012 visitors to a new range of ISO/USP pre-tested MEVOPUR® processing and functionality-enhancing additives designed to address the pharmaceutical packaging sector’s drive for greater cost-efficiency and differentiation.

Change in the Board of Directors of Clariant

Muttenz, 15 February 2012 – At the 17th Annual General Meeting of Clariant Ltd on March 27, 2012, Dr. Jürg Witmer will step down from his roles as Chairman and Member of Clariant Ltd's Board of Directors. The Board has appointed the current Vice-Chairman Dr. Rudolf Wehrli as his successor.

Clariant recommends repeal of restriction on voting rights

Muttenz, 15 February 2012 – Clariant will propose the repeal of the restriction on voting rights for shareholders with a participation of more than 10% of the share capital to the 17th Annual General Meeting on 27 March 2012. In doing so, the Board of Directors is taking up an identical proposal submitted to the company by shareholder zCapital AG (Zug, Switzerland) on 2 February 2012.

Clariant improves profitability, reinstates dividend

  • Full-year sales increased by 16% in local currency and 4% in CHF
  • EBITDA margin before exceptional items rose to 13.2% from 12.7% in 2010
  • Net income improved to CHF 251 million from CHF 191 million in 2010
  • Dividend payment resumed at CHF 0.30 per share through reduction of par value
  • Outlook: Clariant expects further sales growth in local currencies and sustained profitability in 2012 as the global economy is expected to progressively strengthen in the course of the year.

Clariant unveils functionality and processing-boosting MEVOPUR® additives at MD&M

  • On-going expansion of a dedicated portfolio of masterbatches and compounds for medical and pharmaceutical sector
  • Innovative functional and productivity solutions support differentiation and risk minimization
  • Pre-testing of ingredients using extraction data and biological evaluation supports customer development


Charlotte (USA), February 14, 2012 - Clariant unveils its new, extended portfolio of MEVOPUR® additives focused on enhancing functionality and processing in medical device applications at the 2012 MD&M event in Anaheim, USA.

Clariant inspires creativity with confidence at Medtec Europe 2012

Clariant’s launch of a permanent anti-static performance additive extends its recently-introduced additive range featuring ISO10993 / USP23 part 87, 88 Class VI biologically evaluated raw materials. (Photo: Clariant)

  • Launch of permanent antistatic and lubricant systems for plastics extends the recently introduced MEVOPUR® ISO/USP additive range
  • ISO10993 / USP pre-evaluated materials support the industry in establishing a clear extractable profile and simulation of potential leachables

Muttenz, February 9, 2012 - New possibilities to achieve cutting-edge permanent antistatic functionality for medical devices and pharmaceutical packaging take center stage among Clariant’s innovations inspiring improvements in manufacturing process, product function and design appeal on-show at Medtec Europe 2012.

Clariant focuses on innovation for top spot in crop protection auxiliaries

Clariant focuses on innovation for top spot in crop protection auxiliaries. (Photo: Clariant)Muttenz, February 6, 2012 - Clariant, a leading global supplier of specialty chemicals, is putting the focus firmly on products and innovation to enhance its package of support for the crop protection industry. With the promise to bring “a new perspective on science and service”, the producer of high quality adjuvants and other auxiliaries for crop protection formulations is making significant investments to help customers improve efficiency, reduce time to market and increase their competitiveness.